{"schema_version":"1","generated_at":"2026-10-31T02:25:14.364Z","data_as_of":null,"url":"https://www.findmykol.com/kol/benjamin-diamond","json_url":"https://www.findmykol.com/kol/benjamin-diamond/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"benjamin-diamond","name":"Benjamin Diamond","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Miami","institution_url":"https://www.findmykol.com/institution/university-of-miami","city":"Miami","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1992199822","orcid":"0000-0002-8638-9365","openalex":"A5001107991"},"summary":"Benjamin Diamond is an Oncology physician affiliated with University of Miami. OpenAlex indexes 211 publications with 1,909 citations (h-index 22); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":211,"cited_by_count":1909,"h_index":22,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05896228","title":"Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"Benjamin T Diamond, MD","source_url":"https://clinicaltrials.gov/study/NCT05896228","trial_url":"https://www.findmykol.com/trial/NCT05896228"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":17,"shown":3,"withheld":14,"rows":[{"payer":"Janssen Research & Development, LLC","program_year":2025,"amount_usd":19525,"payment_count":10,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992199822"},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":5128.83,"payment_count":9,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992199822"},{"payer":"Janssen Scientific Affairs, LLC","program_year":2025,"amount_usd":42.62,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992199822"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1992199822","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Dermatology","share_pct":47.3,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":47.3,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":15}]},{"area":"Nervous system","share_pct":21.9,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":21.9,"drugs":[{"name":"Oxycodone Hcl","share_pct":53.1},{"name":"Oxycodone-Acetaminophen","share_pct":46.9}],"max_beneficiaries":null}]},{"area":"Blood & clotting","share_pct":17.1,"classes_total":1,"classes":[{"class":"Factor Xa inhibitor","setting":"prescribed","share_pct":17.1,"drugs":[{"name":"Xarelto","share_pct":52},{"name":"Eliquis","share_pct":48}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies","year":2025,"journal":"Blood Advances","source_url":"https://doi.org/10.1182/bloodadvances.2025016911","status":"verified"},{"title":"Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma","year":2025,"journal":"Blood","source_url":"https://doi.org/10.1182/blood.2024028107","status":"verified"},{"title":"Temporal genomic dynamics shape clinical trajectory in multiple myeloma","year":2025,"journal":"Nature Genetics","source_url":"https://doi.org/10.1038/s41588-025-02292-1","status":"verified"},{"title":"Randomized, multi-center study of carfilzomib, lenalidomide, and dexamethasone (KRd) with or without daratumumab (D) in patients with newly diagnosed multiple myeloma (NDMM): The ADVANCE clinical trial.","year":2025,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2025.43.16_suppl.7503","status":"verified"},{"title":"Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell–Redirecting Immunotherapies","year":2025,"journal":"Blood Cancer Discovery","source_url":"https://doi.org/10.1158/2643-3230.bcd-25-0005","status":"verified"}],"source":"works"},"contact":{"address_1":"1475 NW 12TH AVE","city":"Miami","state":"FL","zip":"331361002","phone":"305-689-5555","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1992199822","source":"identity"},"similar":[{"name":"Cynthia Levy","slug":"cynthia-levy","institution":"University of Miami","specialty":"Hepatology","url":"https://www.findmykol.com/kol/cynthia-levy","json_url":"https://www.findmykol.com/kol/cynthia-levy/profile.json"},{"name":"Carlos Singer","slug":"carlos-singer","institution":"University of Miami","specialty":"Neurology","url":"https://www.findmykol.com/kol/carlos-singer","json_url":"https://www.findmykol.com/kol/carlos-singer/profile.json"},{"name":"Sebastian Koch","slug":"sebastian-koch","institution":"University of Miami","specialty":"Neurology","url":"https://www.findmykol.com/kol/sebastian-koch","json_url":"https://www.findmykol.com/kol/sebastian-koch/profile.json"},{"name":"Jay Spiegel","slug":"jay-spiegel","institution":"University of Miami","specialty":"Hematology","url":"https://www.findmykol.com/kol/jay-spiegel","json_url":"https://www.findmykol.com/kol/jay-spiegel/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":14,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2023-04-19","provider_certified":"2023-04-19","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}